We leverage a panel of state-of-the-art separation technologies and follow DoE principles to achieve maximum recovery and purity of target proteins. Required DSP process characterization is performed based on qualified scale-down models and is supported by high-throughput analytical instrumentation.
Our downstream process development capabilities for mammalian cell culture include:
- Allegro™ Single-Use Tangential Flow Filtration
- ÄKTA™ chromatography systems
- Automated systems for filtration optimization
We can support any projects process development and utilize our know-how, state-of-the-art equipment and proprietary technologies to deliver a process optimized for your therapeutic.